Stockreport

MediWound Reports Fourth Quarter and Full Year 2022 Financial Results and Company Update

MediWound Ltd. - Ordinary Shares  (MDWD) 
Last mediwound ltd. - ordinary shares earnings: 2/25 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.mediwound.com/press-releases
PDF 2022 total revenues of $26.5 million FDA approval of NexoBrid® in December 2022; U.S. commercial availability expected in the second quarter of 2023 EscharEx® Phase II [Read more]